Detalhe da pesquisa
1.
Roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic syndrome: Open-label, dose-selection, lead-in stage of a phase 3 study.
Am J Hematol
; 97(2): 174-184, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724251
2.
Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.
J Clin Oncol
; 26(32): 5198-203, 2008 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18824702